Status:
COMPLETED
Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- Thalassemia
Lead Sponsor:
Tanta University
Conditions:
Liver Fibrosis
Beta Thalassemia Major
Eligibility:
All Genders
5-18 years
Brief Summary
The goal of this cross-sectional observational study is to evaluate the accuracy of serum ferritin and serum hepcidin versus non-invasive scores in the diagnosis of liver fibrosis and iron overload in...
Eligibility Criteria
Inclusion
- Children with ß-thalassemia major
- iron overload, as indicated by serum ferritin levels more than 500 ng/mL.
Exclusion
- Pediatric patients with liver diseases (such as hepatitis).
- children with other types of chronic hemolytic anemia.
- other chronic systemic diseases (DM and Hypertension) or malignancy or heart diseases.
Key Trial Info
Start Date :
September 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 2 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07153926
Start Date
September 12 2024
End Date
June 2 2025
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospitals
Tanta, Gharbyea, Egypt, 31516